How common are STDs in pregnancy?
Official statistics show that STDs in pregnancy are very common in the US, and most are silent:
This amounts to over one million cases per year. As there are about 4 million deliveries in the US per year, this means that STDs are a silent threat in upto one quarter (25%) of all US pregnancies.
How common is GBS in pregnancy?
Group B Strep colonization of the vagina in pregnancy is about as common as STDs (10-40% of all pregnancies), but is not itself an STD. Women who are positive for GBS are simply carriers of this common bacterium.
Why are these infections important to diagnose in pregnancy?
The majority of these infections have no symptoms, and the mother is totally unaware of having any problem. They can only be identified by testing, but if left untreated they can produce serious and sometimes fatal complications in both mother and child.
What treatments are available if these infections are diagnosed?
Most of these infections (Chlamydia, Gonorrhoea, Trichomonas and GBS) can be cured by carefully chosen antibiotics. Herpes infections can be minimized with certain anti-viral medications, and Caesarian Section may be recommended as the safest way to deliver the baby.
When should testing be done?
Twice. The first vaginal sample should be taken soon after pregnancy is confirmed to identify and treat any silent STDs before they can harm the developing baby and mother. The second test should be done at 35-37 weeks of pregnancy to see if GBS is present, and also to confirm no new STD.
How is Trovagene testing different from other types of testing for these conditions?
Only our technology uses the 'Gold Standard' method of DNA sequencing to produce results. Trovagene can test for all 6 organisms simultaneously, and produce a single report to help with filing and patient management.